Exploring the Potential of Drug Response Assays for Precision Medicine in Ovarian Cancer
Singh, T.; Neal, A.S.; Moatamed, N.A.; Memarzadeh, S. Exploring the Potential of Drug Response Assays for Precision Medicine in Ovarian Cancer. Int. J. Mol. Sci. 2021, 22, 305. https://doi.org/10.3390/ijms22010305
Singh T, Neal AS, Moatamed NA, Memarzadeh S. Exploring the Potential of Drug Response Assays for Precision Medicine in Ovarian Cancer. International Journal of Molecular Sciences. 2021; 22(1):305. https://doi.org/10.3390/ijms22010305
Chicago/Turabian StyleSingh, Tanya, Adam S. Neal, Neda A. Moatamed, and Sanaz Memarzadeh. 2021. "Exploring the Potential of Drug Response Assays for Precision Medicine in Ovarian Cancer" International Journal of Molecular Sciences 22, no. 1: 305. https://doi.org/10.3390/ijms22010305